Can Long-Term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention?

    October 2017 in “ The Journal of Urology ”
    Steven A. Kaplan
    Image of study
    TLDR Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.
    The document reviewed the effects of long-term pharmacological treatment for benign prostatic hyperplasia (BPH) on surgical intervention outcomes, revealing limited evidence to determine if medical therapy delays surgery or alters the characteristics of men who undergo surgery. It speculated that men receiving surgery might be older, have larger prostates, and more comorbidities, although advancements in surgery and postoperative care could mitigate these factors. The review emphasized the importance of identifying the ideal candidates for surgical versus medical therapy and noted the role of urinary retention and detrusor decompensation in predicting the failure of pharmacological treatment. Lifestyle modifications were mentioned as influential on BPH progression and symptoms. The document also discussed the long-term effects of finasteride, indicating it reduces BPH-related events but may raise depression risk, and addressed the sexual side effects of 5-alpha reductase inhibitors, suggesting these may be underreported despite their efficacy in symptom treatment.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 171 results

      community How is dht not beneficial to you?

      in Finasteride/Dutasteride  111 upvotes 1 month ago
      DHT is important for sexual function and mood, but finasteride and dutasteride can reduce DHT, causing side effects like reduced libido and erectile dysfunction. These treatments are effective for hair loss, but their impact on DHT leads to debate.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      by nkrata in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Wtf have we been doing for the last 30 years

      in Treatment  548 upvotes 1 year ago
      Hair loss treatments like finasteride, minoxidil, and dutasteride work but have side effects. A permanent cure is still not available due to the complexity of hair loss and limited investment.

    Similar Research

    6 / 1000+ results